Biomeme has invented a coronavirus test that can be evaluated outside of traditional lab settings and can deliver accurate results in an hour or less.

The region’s frontrunner in the race to develop a coronavirus vaccine is working through a class action lawsuit and has filed a lawsuit against one of its development partners.

AccessMatters wants to reduce stigma and keep at-risk populations safe from contracting COVID-19 while getting tested for HIV.

Annovis Bio is developing new methods to treat neurodegenerative disorders and brain injuries caused by viral infections like the coronavirus, COVID19.

The longtime head of the region’s largest tech investment firm explains her decision to resign and her wish for entrepreneurs in the life sciences.

The local company has developed a searchable database that helps patients locate doctors, research and clinical trials for chronic and rare health conditions.

Experts from the Children’s Hospital of Philadelphia offer tips on everything from swimming in public pools to choosing child care amid the pandemic.

HealthVerity is partnering with the FDA in the fight against COVID-19.

While black people have accounted for more than half of the coronavirus deaths in Philadelphia, the black community was left to rely on grassroots efforts to bring them testing while the city waited on federal funding.

Philly biotech founder Ben Doranz explains the importance of understanding how COVID-19 antibodies work and why it may be too soon to declare anyone as being immune to the virus.

Would a free cup of coffee or a discount at your favorite clothing store encourage you to keep your distance? The entrepreneur behind this new health platform is betting it might.

The latest guidance on testing methods and sites available across the city.

Philly health experts shed light on newly discovered symptoms and long-term effects of COVID-19.

CHOP doctor and infectious disease expert Paul Offit has a message for people spreading misinformation about vaccines and the virus.